EHRA Premium Access

No more therapy delivery after ventricular tachycardia ablation? Will my patient fear shock again?

Congress Presentation

About the speaker

Doctor Antonio Berruezo Sanchez

Teknon Medical Centre, Barcelona (Spain)
15 presentations
1 follower

4 more presentations in this session

Primary prevention in systolic dysfunction/heart failure patients: use, misuse, and underuse

Speaker: Associate Professor M. Zabel (Goettingen, DE)


Antitachycardia pacing and VT termination: fact or fancy? What is the impact on shock reduction from a patient's perspective?

Speaker: Doctor U. Birgersdotter-Green (San Diego, US)


Noninvasive risk factors for the prediction of inducibility on programmed ventricular stimulation in post-MI patients with ejection fraction over 40% at SCD risk, insights from the PRESERVE EF study

Speaker: Doctor K. Trachanas (Athens, GR)


Sudden death prevention and ICD therapy: unsolved issues - discussion


Access the full session

Sudden death prevention and ICD therapy: unsolved issues

Speakers: Doctor A. Berruezo Sanchez, Associate Professor M. Zabel, Doctor U. Birgersdotter-Green, Doctor K. Trachanas

About the event


EHRA 2021

23 April - 25 April 2021

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb